Innovation Map Houston – Houston Oncology Therapeutics Company Raises 11.4M in Seed Funding
August 27, 2024
News & Publications
In The News
BioWorld – Diakonos Raises $11.4M for Its Dendritic Cell Vaccine
August 27, 2024
Oncology Nursing News – FDA Grants Fast Track Status to Dendritic Cell Vaccine for Pancreatic Cancer
July 23, 2024
CureToday.com – FDA Fast Tracks Pancreatic Cancer Vaccine
July 19, 2024
Vaccine Nation – Diakonos Announces FDA Fast Track Designation for DCV
July 18, 2024
Press Releases
CNS 2024 Conference Presentation: Diakonos Oncology’s Autologous Dendritic Cell Vaccine (DOC1021) Yields 93% 12-Month Survival for Glioblastoma Patients
October 1, 2024
Diakonos Oncology Announces Final Closing of Oversubscribed $11.4M Seed Financing to Advance Its Highly Differentiated Dendritic Cell Vaccine (DOC1021) into a Phase 2 Clinical Trial
August 26, 2024
Diakonos Oncology Receives FDA Fast Track Designation for Pancreatic Cancer Dendritic Cell Vaccine; Names Daniel D. Von Hoff, M.D. to Scientific Advisory Board
July 15, 2024
Diakonos Oncology CFO Anthony Baldor to Provide Corporate Update at BIO International Convention In San Diego, June 3 – 6, 2024
June 3, 2024
Diakonos Oncology’s Unique Dendritic Cell Vaccine (DOC1021) Improves Survival Compared to Standard of Care in Phase 1 Trial for Glioblastoma
April 9, 2024
Company Presentations
AACR 2024 Poster: Vaccine Immunotherapy by Homologous Antigenic Loading as Adjuvant Therapy for Glioblastoma: Ongoing Phase 1 Analysis
April 9, 2024
Publications
Science Translational Medicine: A Unique Subset of Cytotoxic Effector Memory T-cells Enhances CAR T-cell Function against Pancreatic Ductal Adenocarcinoma. Konduri V, Joseph S, Byrd TT, et al.
May 5, 2022
FASEB Journal: MHC class I and II peptide homology regulates the cellular immune response. FASEB. Halpert MM, Konduri V, Liang D, et al.
April 16, 2020
Cancer Gene Therapy: Dendritic cell vaccination plus low-dose Doxorubicin for the treatment of spontaneous canine hemangiosarcoma. Konduri V*, Halpert MM*, et al. Cancer Gene Therapy.
January 23, 2019
Frontiers in Immunology: AIMp1 Potentiates TH1 polarization and is critical for effective antitumor and antiviral immunity. Liang D, Tian L, You R, et al.
January 15, 2018
OncoImmunology: Chemo-immunotherapy mediates durable cure of orthotopic KrasG12D/p53-/- pancreatic ductal adenocarcinoma. Oncoimmunology. Konduri V, Li D, Halpert MM, et al.
July 22, 2016